STEM CELLS GOING TO THE DOGS (Orthopedics This Week)
Aratana Therapeutics, Inc. has entered into an agreement to develop and commercialize a novel stem cell therapy for dogs. The licensor, Vet-Stem, Inc., pioneered the use of adipose tissue (fat) sourced stem cell therapies for veterinary medicine.
If approved, this would become the first FDA-blessed, “off the shelf” regenerative cell therapy for treating osteoarthritis in dogs. As part of the deal, Aratana agreed to invest up to $5 million ($0.5 million contract signing + up to $4.5 million in milestone based payments) for R&D and to pay ...
